At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 68 enrolled
Drug / intervention
omega-3 supplementation +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
National Center for Complementary and Integrative Health (NCCIH)·interventional·Posted Aug 23, 2007·Updated Mar 27, 2012
In Brief
A Phase 2 clinical trial evaluating omega-3 supplementation and Oral omega-3 fish oil placebo for Stress-related Changes in Inflammation. Completed, enrolled 68 participants across 1 site.
Detailed Summary
This study is designed to examine the effects of fish oil on immune function and mood in medical students.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress-related Changes in Inflammation
CountriesUnited States
CollaboratorsOffice of Dietary Supplements (ODS)
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
First PostedAug 2007
Primary CompletionDec 2008
Study CompletionDec 2010
TodayJul 2026
First PostedAug 23, 2007
Enrollment StartJul 1, 2007
Primary CompletionDec 1, 2008
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.9 years ago
Interventions
omega-3 supplementationdietary
2.5 g/day omega-3
Oral omega-3 fish oil placebodietary
to match experimental dosage